Wells Fargo & Company Personalis, Inc. Transaction History

Wells Fargo & Company

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.15 - $2.19 $5 - $10	5 Added 1.66%	307 $0
Q4 2023 Feb 09, 2024	BUY	$0.93 - $2.35 $17 - $44	19 Added 6.71%	302 $0
Q3 2023 Nov 13, 2023	BUY	$1.19 - $2.36 $8 - $16	7 Added 2.54%	283 $0
Q2 2023 Aug 15, 2023	BUY	$1.8 - $3.19 $27 - $47	15 Added 5.75%	276 $0
Q1 2023 May 12, 2023	BUY	$2.01 - $4.17 $8 - $16	4 Added 1.56%	261 $0
Q4 2022 Feb 13, 2023	SELL	$1.78 - $2.87 $8,791 - $14,174	-4,939 Reduced 95.05%	257 $0
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.32 $13,181 - $23,067	4,336 Added 504.19%	5,196 $15,000
Q2 2022 Aug 12, 2022	SELL	$3.27 - $8.76 $33,494 - $89,728	-10,243 Reduced 92.25%	860 $3,000
Q1 2022 May 16, 2022	SELL	$7.56 - $14.3 $92,972 - $175,861	-12,298 Reduced 52.55%	11,103 $91,000
Q4 2021 Feb 14, 2022	SELL	$12.24 - $21.25 $249,891 - $433,840	-20,416 Reduced 46.59%	23,401 $333,000
Q3 2021 Nov 15, 2021	SELL	$16.69 - $26.05 $27,955 - $43,633	-1,675 Reduced 3.68%	43,817 $843,000
Q2 2021 Aug 16, 2021	BUY	$18.15 - $27.75 $407,394 - $622,876	22,446 Added 97.4%	45,492 $1.15 Million
Q1 2021 May 13, 2021	SELL	$20.71 - $51.02 $520,028 - $1.28 Million	-25,110 Reduced 52.14%	23,046 $568,000
Q4 2020 Feb 09, 2021	BUY	$21.84 - $44.0 $166,180 - $334,796	7,609 Added 18.77%	48,156 $1.76 Million
Q3 2020 Nov 05, 2020	SELL	$13.63 - $24.12 $80,117 - $141,777	-5,878 Reduced 12.66%	40,547 $879,000
Q2 2020 Aug 13, 2020	BUY	$7.65 - $14.11 $119,171 - $219,805	15,578 Added 50.5%	46,425 $603,000
Q1 2020 May 14, 2020	BUY	$4.75 - $12.41 $146,523 - $382,811	30,847 New	30,847 $249,000

22.3M

27.5K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $237M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.